| Article
A pre-planned analysis of the CARD trial (NCT02485691) demonstrated better patient-reported outcomes (PROs) with cabazitaxel (Jevtana) compared with either abiraterone (Zytiga) or enzalutamide (Xtandi) in men with metastatic castration-resistant prostate cancer (mCRPC) who were previously treated...
| Video
Clinical pharmacist Mark Garofoli offers a strategic thought process for appropriate selection of medications for patients with muscle spasm and/or muscle spasticity.
| Article
Newswise — A visit to the doctor’s office typically begins with a series of questions, including one about medications. An Iowa State University researcher recommends doctors ask a follow up to that question to make sure patients are taking their medications as prescribed.
Alison Phillips, an...